Novo Nordisk said Thursday that the rampant growth of the U.S.' compounded drug industry was hurting Wegovy sales, and warned ...

A groundbreaking study from the University of British Columbia has revealed a potentially disturbing side effect for those ...

Novo Nordisk has updated its Wegovy savings program, allowing eligible cash-paying patients to access the drug at retail ...

A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

The newest generation of GLP-1 drugs has delivered life-changing benefits to patients managing diabetes, obesity, heart ...

The Wegovy-savings program provides another secure option for individuals living with obesity to access the authentic, FDA-approved drug from trusted ... regulatory review. However, the Novo ...

Semaglutide is the active ingredient in Wegovy It is also the main component ... compared the effects of users taking semaglutide-based drugs to those taking Contrave, a bupropion/naltrexone ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy will have the option to buy now and pay later under a partnership announced Tuesday by ...

Weight loss “wonder drug” Wegovy will cost Irish users around €220 a month as it is not currently availably under either the Drug Payments Scheme or free to medical card holders. Wegovy has ...